Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 2
1965 1
1969 1
1971 1
1974 1
1975 1
1979 1
1983 2
1984 4
1985 4
1986 4
1987 4
1988 4
1989 2
1990 7
1991 3
1992 7
1993 11
1994 13
1995 18
1996 7
1997 10
1998 11
1999 12
2000 24
2001 27
2002 35
2003 26
2004 30
2005 32
2006 25
2007 41
2008 49
2009 63
2010 94
2011 107
2012 120
2013 141
2014 163
2015 152
2016 184
2017 190
2018 184
2019 217
2020 269
2021 316
2022 323
2023 45
Text availability
Article attribute
Article type
Publication date

Search Results

2,656 results
Results by year
Filters applied: . Clear all
Page 1
Mechanisms of Resistance to KRASG12C-Targeted Therapy.
Akhave NS, Biter AB, Hong DS. Akhave NS, et al. Among authors: hong ds. Cancer Discov. 2021 Jun;11(6):1345-1352. doi: 10.1158/2159-8290.CD-20-1616. Epub 2021 Apr 5. Cancer Discov. 2021. PMID: 33820777 Free PMC article. Review.
Sotorasib for previously treated colorectal cancers with KRASG12C mutation (CodeBreaK100): a prespecified analysis of a single-arm, phase 2 trial.
Fakih MG, Kopetz S, Kuboki Y, Kim TW, Munster PN, Krauss JC, Falchook GS, Han SW, Heinemann V, Muro K, Strickler JH, Hong DS, Denlinger CS, Girotto G, Lee MA, Henary H, Tran Q, Park JK, Ngarmchamnanrith G, Prenen H, Price TJ. Fakih MG, et al. Among authors: hong ds. Lancet Oncol. 2022 Jan;23(1):115-124. doi: 10.1016/S1470-2045(21)00605-7. Epub 2021 Dec 15. Lancet Oncol. 2022. PMID: 34919824 Clinical Trial.
Engineered T-cell Receptor T Cells for Cancer Immunotherapy.
Greenbaum U, Dumbrava EI, Biter AB, Haymaker CL, Hong DS. Greenbaum U, et al. Among authors: hong ds. Cancer Immunol Res. 2021 Nov;9(11):1252-1261. doi: 10.1158/2326-6066.CIR-21-0269. Cancer Immunol Res. 2021. PMID: 34728535 Review.
Randomized Trial of Irinotecan and Cetuximab With or Without Vemurafenib in BRAF-Mutant Metastatic Colorectal Cancer (SWOG S1406).
Kopetz S, Guthrie KA, Morris VK, Lenz HJ, Magliocco AM, Maru D, Yan Y, Lanman R, Manyam G, Hong DS, Sorokin A, Atreya CE, Diaz LA, Allegra C, Raghav KP, Wang SE, Lieu CH, McDonough SL, Philip PA, Hochster HS. Kopetz S, et al. Among authors: hong ds. J Clin Oncol. 2021 Feb 1;39(4):285-294. doi: 10.1200/JCO.20.01994. Epub 2020 Dec 23. J Clin Oncol. 2021. PMID: 33356422 Free PMC article. Clinical Trial.
Intrinsic Immunogenicity of Small Cell Lung Carcinoma Revealed by Its Cellular Plasticity.
Mahadevan NR, Knelson EH, Wolff JO, Vajdi A, Saigí M, Campisi M, Hong D, Thai TC, Piel B, Han S, Reinhold BB, Duke-Cohan JS, Poitras MJ, Taus LJ, Lizotte PH, Portell A, Quadros V, Santucci AD, Murayama T, Cañadas I, Kitajima S, Akitsu A, Fridrikh M, Watanabe H, Reardon B, Gokhale PC, Paweletz CP, Awad MM, Van Allen EM, Lako A, Wang XT, Chen B, Hong F, Sholl LM, Tolstorukov MY, Pfaff K, Jänne PA, Gjini E, Edwards R, Rodig S, Reinherz EL, Oser MG, Barbie DA. Mahadevan NR, et al. Among authors: hong d. Cancer Discov. 2021 Aug;11(8):1952-1969. doi: 10.1158/2159-8290.CD-20-0913. Epub 2021 Mar 11. Cancer Discov. 2021. PMID: 33707236 Free PMC article.
The polyG diseases: a new disease entity.
Liufu T, Zheng Y, Yu J, Yuan Y, Wang Z, Deng J, Hong D. Liufu T, et al. Among authors: hong d. Acta Neuropathol Commun. 2022 May 31;10(1):79. doi: 10.1186/s40478-022-01383-y. Acta Neuropathol Commun. 2022. PMID: 35642014 Free PMC article. Review.
Tropicamide.
Hong D, Tripathy K. Hong D, et al. 2022 Nov 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan–. 2022 Nov 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan–. PMID: 31082113 Free Books & Documents.
The CGG repeat expansion in RILPL1 is associated with oculopharyngodistal myopathy type 4.
Yu J, Shan J, Yu M, Di L, Xie Z, Zhang W, Lv H, Meng L, Zheng Y, Zhao Y, Gang Q, Guo X, Wang Y, Xi J, Zhu W, Da Y, Hong D, Yuan Y, Yan C, Wang Z, Deng J. Yu J, et al. Among authors: hong d. Am J Hum Genet. 2022 Mar 3;109(3):533-541. doi: 10.1016/j.ajhg.2022.01.012. Epub 2022 Feb 10. Am J Hum Genet. 2022. PMID: 35148830 Free PMC article.
Skeletal muscle NOX4 is required for adaptive responses that prevent insulin resistance.
Xirouchaki CE, Jia Y, McGrath MJ, Greatorex S, Tran M, Merry TL, Hong D, Eramo MJ, Broome SC, Woodhead JST, D'souza RF, Gallagher J, Salimova E, Huang C, Schittenhelm RB, Sadoshima J, Watt MJ, Mitchell CA, Tiganis T. Xirouchaki CE, et al. Among authors: hong d. Sci Adv. 2021 Dec 17;7(51):eabl4988. doi: 10.1126/sciadv.abl4988. Epub 2021 Dec 15. Sci Adv. 2021. PMID: 34910515 Free PMC article.
2,656 results